GADOQUATRANE
UNII OZG7J613HK

Substance Identification & Data

This profile provides standardized clinical and technical data for Gadoquatrane, uniquely identified by the FDA Unique Ingredient Identifier (UNII) OZG7J613HK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2048221-65-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

OZG7J613HK

CAS Registry Number

2048221-65-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

GADOQUATRANE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C81H128N24O32.4Gd

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

HGIZCBUSWUYZEQ-UHFFFAOYSA-B

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C184920

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

156596411

Unique identification number in the NCBI database of chemical substances.

INN ID

11850

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-190

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1CN(CCN(CCN(CCN1CC([O-])=O)CC([O-])=O)C(C(NCC(NCC(CNC(CNC(C(N2CCN(CC(=O)[O-])CCN(CC(=O)[O-])CCN(CC(=O)[O-])CC2)C)=O)=O)(CNC(CNC(=O)C(N3CCN(CC(=O)[O-])CCN(CC(=O)[O-])CCN(CC(=O)[O-])CC3)C)=O)CNC(CNC(C(N4CCN(CC(=O)[O-])CCN(CC(=O)[O-])CCN(CC(=O)[O-])CC4)C)=O)=O)=O)=O)C)CC([O-])=O.[Gd+3].[Gd+3].[Gd+3].[Gd+3]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Gadoquatrane. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GADOQUATRANE

Common Names & Synonyms

GADOQUATRANE [INN]

GADOQUATRANE [USAN]

Systematic Nomenclature

GADOLINIUM, (.MU.4-((10,10'-((2,2-BIS(((2-((1-(OXO-.KAPPA.O)-2-(4,7,10-TRIS((CARBOXY-.KAPPA.O)METHYL)-1,4,7,10-TETRAAZACYCLODODEC-1-YL-.KAPPA.N1,.KAPPA.N4,.KAPPA.N7,.KAPPA.N10)PROPYL)AMINO)ACETYL)AMINO)METHYL)-1,3-PROPANEDIYL)BIS(IMINO(2-OXO-2,1-ETHANEDIYL)IMINO(1-METHYL-2-(OXO-.KAPPA.O)-2,1-ETHANEDIYL)))BIS(1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETATO-.KAPPA.N1,.KAPPA.N4,.KAPPA.N7,.KAPPA.N10,.KAPPA.O1,.KAPPA.O4,.KAPPA.O7))(12-)))TETRA-.KAPPA.N1,.KAPPA.N4,.KAPPA.N7,.KAPPA.N10,.KAPPA.O1,.KAPPA.O4,.KAPPA.O7))(12-)))TETRA-

SYS

TETRAGADOLINIUM (4,10-BIS(CARBOXYLATOMETHYL)-7-(3,6,12,15- TETRAOXO-16-(4,7,10-TRIS- (CARBOXYLATOMETHYL)-1,4,7,10- TETRAAZACYCLODODECAN-1-YL)-9,9-BIS(((((2-(4,7,10-TRIS- (CARBOXYLATOMETHYL)-1,4,7,10-TETRAAZACYCLODODECAN-1- YL)PROPANOYL)AMINO)ACETYL)-AMINO)METHYL)- 4,7,11,14- TETRAAZAHEPTADECAN-2-YL)-1,4,7,10-TETRAAZACYCLODODECAN-1- YL)ACETATE

SYS